Yiling Pharma

Yiling Pharmaceutical Co., Ltd., commonly known as Yiling Pharma, is a renowned Chinese pharmaceutical company headquartered in Shijiazhuang, Hebei Province, China. Established in 1992, Yiling Pharma has become a leading player in the pharmaceutical industry, particularly in the research, development, manufacturing, and marketing of traditional Chinese medicines (TCMs) and other modern pharmaceutical products.

The company is well-known for its flagship product, "Lianhua Qingwen Capsule," which is a TCM-based medicine. This product gained significant attention during the SARS outbreak in 2003 and has been used in the management of respiratory tract infections, cold, and flu-like symptoms. Yiling Pharma's success with Lianhua Qingwen Capsule has contributed to its strong market presence both within China and internationally.

Yiling Pharma's product portfolio extends beyond traditional Chinese medicines, including chemical-based pharmaceuticals, herbal medicines, and healthcare products in various therapeutic areas, such as cardiovascular, respiratory, and digestive disorders.

The company emphasizes research and development, with a focus on integrating modern scientific advancements with traditional Chinese medicine practices. It collaborates with academic institutions and research organizations to enhance its product offerings and advance its technology.

Yiling Pharmaceutical Co., Ltd. also has a well-established distribution network that ensures its products are widely available throughout China. Additionally, it has expanded its global presence through partnerships and exports to other countries.

Founded: 1992

Founder: Yiling Pharmaceutical Co., Ltd

Headquarters: Shijiazhuang, Hebei Province, China

Website: https://en.yiling.com/